ArticleDentistry journal2022

Oral Side Effects in Patients with Metastatic Renal Cell Carcinoma Receiving the Antiangiogenic Agent Pazopanib-Report of Three Cases.

Erofili Papadopoulou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.